SONX Stock Overview
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Sonendo, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.091 |
52 Week High | US$1.80 |
52 Week Low | US$0.045 |
Beta | 1.66 |
1 Month Change | -13.71% |
3 Month Change | -40.36% |
1 Year Change | -93.39% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -99.02% |
Recent News & Updates
Recent updates
Analysts Have Just Cut Their Sonendo, Inc. (NYSE:SONX) Revenue Estimates By 18%
Nov 10A Piece Of The Puzzle Missing From Sonendo, Inc.'s (NYSE:SONX) Share Price
Apr 19Sonendo unit PIPStek files patent infringement lawsuit against Biolase
Jan 04GAAP EPS of -$0.47 misses by $0.08, revenue of $9.8M beats by $0.49M
Nov 09Sonendo announces $63 million private placement
Sep 23Sonendo: Painful Debut For This Dental Play
Nov 07Shareholder Returns
SONX | US Medical Equipment | US Market | |
---|---|---|---|
7D | -1.5% | 1.4% | 1.2% |
1Y | -93.4% | -0.7% | 24.7% |
Return vs Industry: SONX underperformed the US Medical Equipment industry which returned -0.7% over the past year.
Return vs Market: SONX underperformed the US Market which returned 24.7% over the past year.
Price Volatility
SONX volatility | |
---|---|
SONX Average Weekly Movement | 20.8% |
Medical Equipment Industry Average Movement | 7.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SONX's share price has been volatile over the past 3 months.
Volatility Over Time: SONX's weekly volatility (21%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 208 | Bjarne Bergheim | sonendo.com |
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system.
Sonendo, Inc. Fundamentals Summary
SONX fundamental statistics | |
---|---|
Market cap | US$6.38m |
Earnings (TTM) | -US$60.92m |
Revenue (TTM) | US$43.87m |
0.1x
P/S Ratio-0.1x
P/E RatioIs SONX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SONX income statement (TTM) | |
---|---|
Revenue | US$43.87m |
Cost of Revenue | US$31.56m |
Gross Profit | US$12.31m |
Other Expenses | US$73.23m |
Earnings | -US$60.92m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.86 |
Gross Margin | 28.05% |
Net Profit Margin | -138.88% |
Debt/Equity Ratio | 131.5% |
How did SONX perform over the long term?
See historical performance and comparison